Patent Assignment
Reel/Frame 024361/0782
Assignment of Assignor's Interest
Recorded: 2010-05-10
Pages: 17
Assignors
ESAU, CHRISTINE
Executed: 2004-08-27
LOLLO, BRIDGET
Executed: 2004-08-27
BENNETT, C. FRANK
Executed: 2004-09-03
FREIER, SUSAN M.
Executed: 2004-08-24
GRIFFEY, RICHARD H.
Executed: 2004-08-24
BAKER, BRENDA F.
Executed: 2004-08-24
VICKERS, TIMOTHY A.
Executed: 2004-09-01
MARCUSSON, ERIC G.
Executed: 2004-08-27
KOLLER, ERICH
Executed: 2004-08-27
SWAYZE, ERIC E.
Executed: 2004-09-07
JAIN, RAVI
Executed: 2004-08-25
BHAT, BALKRISHEN
Executed: 2004-08-27
PERALTA, EIGEN R.
Executed: 2004-08-25
Assignee
ISIS PHARMACEUTICALS, INC.
2292 FARADAY AVENUE, CARLSBAD, CALIFORNIA, 92008
Covered Properties
(8)
Oligomeric Compounds and Compositions for Use in Modulation of Pri-Mirnas
Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding Rnas
Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
Application:
12/345,811 →
Publication:
US 2009/0286969
Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding Rnas
Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding Rnas
Oligomeric Compounds and Compositions for Use in Modulation of Small Non-Coding Rnas
Method for Inhibiting the Activity of Mir-155
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 2, 2006
From: LOLLO, BRIDGET; JAIN, RAVI
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 017245/0001 →
Assignment of Assignor's Interest
Nov 8, 2007
From: ISIS PHARMACEUTICALS, INC.
To: REGULUS THERAPEUTICS, LLC
Reel/Frame 020085/0730 →
Change of Name
Feb 12, 2009
From: REGULUS THERAPEUTICS, LLC
To: REGULUS THERAPEUTICS, INC.
Reel/Frame 022260/0041 →
Change of Name
May 10, 2010
From: REGULUS THERAPEUTICS, LLC
To: REGULUS THERAPEUTICS INC.
Reel/Frame 024362/0224 →
Assignment of Assignor's Interest
May 10, 2010
From: ISIS PHARMACEUTICALS, INC.
To: REGULUS THERAPEUTICS, LLC
Reel/Frame 024361/0870 →
Security Interest
Aug 8, 2018
From: REGULUS THERAPEUTICS INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
Reel/Frame 046748/0561 →
Release of Security Interest
May 14, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
To: REGULUS THERAPEUTICS INC.
Reel/Frame 067402/0782 →